Drug interactions in the elderly with coronary artery disease - Do these interfere with effective therapy?

American Journal of Geriatric Cardiology

Volumn 7, Issue 1, 1998, Pages 14-21

  Schwartz, Janice B ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA METHYLDOPAMINE; AMIODARONE; AMLODIPINE; ANTIARRHYTHMIC AGENT; ANTIDEPRESSANT AGENT; ANTIINFECTIVE AGENT; ANTILIPEMIC AGENT; ANTIRHEUMATIC AGENT; ANTIULCER AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; CLONIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; FELODIPINE; LABETALOL; METOPROLOL; MEXILETINE; ORAL ANTIDIABETIC AGENT; PRAZOSIN; PROPAFENONE; PROPRANOLOL; QUINIDINE; SPIRONOLACTONE; TERAZOSIN; UNINDEXED DRUG;

AGED; ARTICLE; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG ELIMINATION; ELDERLY CARE; HUMAN; PHARMACODYNAMICS;

EID: 0031975178     PISSN: 10767460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Denham M. Adverse drug reactions. British Medical Bulletin. 1990;46(1):53-62.
2. Carbonin P, Pahor M, Bernabei R, et al. Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc. 1991;39:1093-1099.
3. Gurwitz JH, Avorn J. The ambiguous relation between aging and adverse drug reactions. Ann Intern Med. 1991;114:956-966.
4. Nolan L, O'Malley K. The need for a more rational approach to drug prescribing for elderly people in nursing homes. Age Aging. 1989;18:52-56.
5. Ryan T, Anderson J, Antman E, et al. ACC/AHA Guidelines for the management of patients with acute myocardial infarction: Executive summary. Circulation. 1996;94: 2341-2350.
6. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
7. Bailey D, Arnold J, Munoz C, et al. Grapefruit juice-felodipine interaction: Mechanism, predictability and effect of naringin. Clin Pharmacol Ther. 1993;53:637-642.
8. Spence J. Drug interactions with grapefruit: Whose responsibility is it to warn the public? Clin Pharmacol Ther. 1997;61(4):395-400.
9. Walter-Sack I, Klotz U. Influence of diet and nutritional status on drug metabolism. Clin Pharmacokin. 1996;31(1):47-64.
10. Goodman and Gilman. The Pharmacological Basis of Therapy. 9th Ed, Hardman JG, Limbird LE, Molinoff PB, et al. (eds). New York: McGraw-Hill; 1996.
11. Hirsh J, Dalen J, Deykin D, et al. Oral Anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 1995;108(4):231S-246S.
12. Committee. Current standards of practice: Oral anticoagulation for older adults. New York, New York: American Geriatric Society, 1996.
13. Dalen J, Hirsh J. Fourth ACCP Consensus Conference on Antithrombotic Therapy. Chest. 1995;108:225S-522S.
14. Harris R, Benet L, Schwartz J. Gender effects in pharmacokinetics and pharmacodynamics. Drugs. 1995;50(2):222-239.
15. Beers M, Ouslande JG. Risk factors in geriatric drug prescribing: A practical guide to avoiding problems. Drugs. 1989;37:105-112.
16. Chrischilles EA, Foley DJ, Wallace RB, et al. Use of medications by persons 65 and over: Data from the Established Populations for Epidemiologic Studies of the Elderly. J Gerontol. 1992;47:M137-144.
17. Brown MM, Boosinger JK, Henderson M, et al. Drug-drug interactions among residents in homes for the elderly. Nurs Res. 1977;26:47-52.
18. Johnson RE, Vollmer WM. Comparing sources of drug data about the elderly. J Am Geriatr Soc. 1991;39:1079-1084.
19. Ray WA, Sederspiel CF, Schaffner W. The study of antipsychotic use in nursing homes: Epidemiologic evidence suggesting misuse. Am J Public Health. 1980;70:485-491.
20. Murray M, Brater D. Renal toxicity of the nonsteriodal anti-inflammatory drugs. Rev Pharmacol & Toxicol. 1993;33:435-465.
21. Pratt C, Hertz R, Ellis BE, et al. Risk of developing life-threatening ventricular arrhythmia associated with terfenadine in comparison with over-the-counter antihistamines, ibuprofen, and clemastine. Am J Cardiol. 1994;73:346-352.
22. Woosley R, Chen Y, Freiman J, et al. Mechanism of the cardiotoxic actions of terfenadine. JAMA. 1993;269:1532-1536.
23. Monahan B, Ferguson C, Killeavy E, et al. Torsades de pointes occurring in association with terfenadine use. JAMA. 1990;264:2788-2790.
24. Vishwanath B, Navalgund A, Cusano W, et al. Fluoxetine as a cause of SIADH. Am J Psychiatry. 1990;148:542-543.
25. Siegler E, Tamres D, Berlin J, et al. Risk factors for the development of hyponatremia in psychiatric inpatients. Arch Intern Med. 1995;155:953-957.